SCHEMBL22449342

SCHEMBL22449342

C#CC1CCCCC1NC(=O)c1ccccn1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRM5 P41594 7/20 0.56
▸ NPC1 O15118 3/20 0.47
▸ ALDH1A1 P00352 3/20 0.47
▸ RAB9A P51151 3/20 0.47
▸ GAA P10253 3/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ MAPT P10636 2/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ SMYD3 Q9H7B4 1/20 0.47
▸ EGFR P00533 1/20 0.46
▸ ERBB2 P04626 1/20 0.46
▸ MET P08581 1/20 0.46
▸ KDR P35968 1/20 0.46
▸ MERTK Q12866 1/20 0.46
▸ CRBN Q96SW2 1/20 0.46
▸ KDM4E B2RXH2 2/20 0.44
▸ GRM4 Q14833 1/20 0.44
▸ CNR2 P34972 1/20 0.43
▸ POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7197995 0.86 GRM5 (0.68) GRM5NPC1ALDH1A1RAB9AGAA
SCHEMBL29590900 0.86 GRM5 (0.68) GRM5NPC1ALDH1A1RAB9AGAA
SCHEMBL23425256 0.86 GRM5 (0.68) GRM5NPC1ALDH1A1RAB9AGAA
SCHEMBL7218492 0.86 GRM5 (0.68) GRM5NPC1ALDH1A1RAB9AGAA
SCHEMBL30043552 0.83 GRM5 (0.61) GRM5GAACYP1A2SMYD3EGFR
SCHEMBL30044693 0.83 GRM5 (0.61) GRM5GAACYP1A2SMYD3EGFR
SCHEMBL30043283 0.83 GRM5 (0.61) GRM5GAACYP1A2SMYD3EGFR
SCHEMBL4735546 0.81 TAS1R3 (0.44) NPC1ALDH1A1RAB9AGAASMN1; SMN2
SCHEMBL30975217 0.81 GRM5 (0.65) GRM5NPC1ALDH1A1RAB9AGAA
SCHEMBL30044039 0.81 GRM5 (0.65) GRM5NPC1ALDH1A1RAB9AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200317615-A1 PALLADIUM (II)-CATALYZED gammaC(SP3)-H ALKYNYLATION OF AMINE2 COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2020-10-08 — — US disclosed
US-10787418-B1 Palladium (II)-catalyzed γC(SP3)-H alkynylation of amines COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2020-09-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200317615-A1 PALLADIUM (II)-CATALYZED gammaC(SP3)-H ALKYNYLATION OF AMINE2 POLE3, BUB3, POLR2H GRM5 1562/4885NPC1 4151/4885ALDH1A1 2497/4885
US-10787418-B1 Palladium (II)-catalyzed γC(SP3)-H alkynylation of amines POLE3, BUB3, POLR2H GRM5 1659/4885NPC1 4039/4885ALDH1A1 2577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback